These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 836115)

  • 41. Blood requirement and subtotal parathyroidectomy in patients with chronic renal failure treated with hemodialysis.
    Szücs J; Makó J; Mérey J
    Clin Nephrol; 1983 Mar; 19(3):134-6. PubMed ID: 6839563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Financial impact of anemia in patients with chronic renal insufficiency undergoing hemodialysis at centers].
    Rousseau P
    Nephrologie; 1990; 11(3):147-52. PubMed ID: 2234271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of anemia caused by chronic kidney failure in adults].
    Nephrol Ther; 2005 Aug; 1 Suppl 1():S1-48. PubMed ID: 16895707
    [No Abstract]   [Full Text] [Related]  

  • 45. Important cost differences of blood transfusions and erythropoietin between hemodialysis and peritoneal dialysis patients.
    Pagé DE; House A
    Adv Perit Dial; 1998; 14():87-9. PubMed ID: 10649699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythropoietin treatment improves quality of life in hemodialysis patients.
    Bárány P; Pettersson E; Bergström J
    Scand J Urol Nephrol Suppl; 1990; 131():55-60. PubMed ID: 2075471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anemia in chronic renal insufficiency--case report].
    Popović M
    Med Pregl; 1999; 52(6-8):279-81. PubMed ID: 10518388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of recombinant human erythropoietin on thrombocyte aggregation capacity and on the blood prostanoid level in patients with chronic kidney failure on hemodialysis].
    Rud'ko IA; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
    Ter Arkh; 1991; 63(10):128-30. PubMed ID: 1805410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
    Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
    Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Recombinant human erythropoietin].
    Frenken LA; Koene RA
    Ned Tijdschr Geneeskd; 1988 Mar; 132(10):432-4. PubMed ID: 3347279
    [No Abstract]   [Full Text] [Related]  

  • 51. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
    Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
    Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of oral iron on the anaemia of patients on maintenance haemodialysis.
    Wallace MR
    N Z Med J; 1971 Sep; 74(471):167-70. PubMed ID: 5289829
    [No Abstract]   [Full Text] [Related]  

  • 53. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
    Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients.
    Huraib S; al-Momen AK; Gader AM; Mitwalli A; Sulimani F; Abu-Aisha H
    Clin Nephrol; 1991 Nov; 36(5):252-7. PubMed ID: 1752076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Degree of anemia in terminal kidney insufficiency during treatment with programmed hemodialysis and blood transfusions].
    Shinkarenko NP
    Vrach Delo; 1980 Nov; (11):92-4. PubMed ID: 7467272
    [No Abstract]   [Full Text] [Related]  

  • 57. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
    Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
    Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anemia in kidney insufficiency, during chronic hemodialysis and following kidney transplantation].
    Schulz W
    Med Klin; 1975 May; 70(20):909-13. PubMed ID: 1094257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.